146 related articles for article (PubMed ID: 27458100)
1. Knockdown of HVEM, a Lymphocyte Regulator Gene, in Ovarian Cancer Cells Increases Sensitivity to Activated T Cells.
Zhang T; Ye L; Han L; He Q; Zhu J
Oncol Res; 2016; 24(3):189-96. PubMed ID: 27458100
[TBL] [Abstract][Full Text] [Related]
2. ERRATUM.
Zhang T; Ye L; He Q; Zhu J
Oncol Res; 2017 Nov; 25(9):1665. PubMed ID: 29096738
[TBL] [Abstract][Full Text] [Related]
3. HVEM/HIF-1α promoted proliferation and inhibited apoptosis of ovarian cancer cells under hypoxic microenvironment conditions.
Duan L; Tao J; Yang X; Ye L; Wu Y; He Q; Duan Y; Chen L; Zhu J
J Ovarian Res; 2020 Apr; 13(1):40. PubMed ID: 32312328
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
[TBL] [Abstract][Full Text] [Related]
5. A herpesvirus entry mediator mutein with selective agonist action for the inhibitory receptor B and T lymphocyte attenuator.
Šedý JR; Balmert MO; Ware BC; Smith W; Nemčovičova I; Norris PS; Miller BR; Aivazian D; Ware CF
J Biol Chem; 2017 Dec; 292(51):21060-21070. PubMed ID: 29061848
[TBL] [Abstract][Full Text] [Related]
6. CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells.
Šedý JR; Bjordahl RL; Bekiaris V; Macauley MG; Ware BC; Norris PS; Lurain NS; Benedict CA; Ware CF
J Immunol; 2013 Jul; 191(2):828-36. PubMed ID: 23761635
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells.
Tao R; Wang L; Murphy KM; Fraser CC; Hancock WW
J Immunol; 2008 May; 180(10):6649-55. PubMed ID: 18453584
[TBL] [Abstract][Full Text] [Related]
8. Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma.
Migita K; Sho M; Shimada K; Yasuda S; Yamato I; Takayama T; Matsumoto S; Wakatsuki K; Hotta K; Tanaka T; Ito M; Konishi N; Nakajima Y
Cancer; 2014 Mar; 120(6):808-17. PubMed ID: 24249528
[TBL] [Abstract][Full Text] [Related]
9. Fragments of gD Protein as Inhibitors of BTLA/HVEM Complex Formation-Design, Synthesis, and Cellular Studies.
Kuncewicz K; Battin C; Sieradzan A; Karczyńska A; Orlikowska M; Wardowska A; Pikuła M; Steinberger P; Rodziewicz-Motowidło S; Spodzieja M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238640
[TBL] [Abstract][Full Text] [Related]
10. The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells.
Gertner-Dardenne J; Fauriat C; Orlanducci F; Thibult ML; Pastor S; Fitzgibbon J; Bouabdallah R; Xerri L; Olive D
Blood; 2013 Aug; 122(6):922-31. PubMed ID: 23692853
[TBL] [Abstract][Full Text] [Related]
11. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
[TBL] [Abstract][Full Text] [Related]
12. Herpesvirus entry mediator regulates the transduction of Tregs via STAT5/Foxp3 signaling pathway in ovarian cancer cells.
Shan Y; Zhang B; Chen L; Zhang H; Jiang C; You Q; Li Y; Han H; Zhu J
Anticancer Drugs; 2023 Jan; 34(1):73-80. PubMed ID: 35946515
[TBL] [Abstract][Full Text] [Related]
13. Role of BTLA/HVEM network in development of gastric cancer.
Azarafza M; Tehrani M; Valadan R; Maleki I; Mohammad Mehdi Ghaffari-Hamedani S; Ghanadan A; Alizadeh-Navaei R; Ajami A
Hum Immunol; 2022; 83(8-9):637-644. PubMed ID: 35914980
[TBL] [Abstract][Full Text] [Related]
14. Modulation of T cell proliferation through the LIGHT-HVEM-BTLA cosignaling pathway.
Cheung TC
Recent Pat DNA Gene Seq; 2009; 3(3):177-82. PubMed ID: 19702559
[TBL] [Abstract][Full Text] [Related]
15. The role of the BTLA-HVEM complex in the pathogenesis of breast cancer.
Hu X
Breast Cancer; 2024 May; 31(3):358-370. PubMed ID: 38483699
[TBL] [Abstract][Full Text] [Related]
16. A crucial role for HVEM and BTLA in preventing intestinal inflammation.
Steinberg MW; Turovskaya O; Shaikh RB; Kim G; McCole DF; Pfeffer K; Murphy KM; Ware CF; Kronenberg M
J Exp Med; 2008 Jun; 205(6):1463-76. PubMed ID: 18519647
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and characterization of TNFSF14 (LIGHT) and its receptor TNFRSF14 (HVEM) in guinea pig (Cavia porcellus).
Li C; Chen S; Song J; Liu H; Gu W; Ai H; Zhao B; Zhang S
Gene; 2013 Sep; 526(2):374-84. PubMed ID: 23732292
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT.
Kojima R; Kajikawa M; Shiroishi M; Kuroki K; Maenaka K
J Mol Biol; 2011 Nov; 413(4):762-72. PubMed ID: 21959263
[TBL] [Abstract][Full Text] [Related]
19. Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses.
Spodzieja M; Lach S; Iwaszkiewicz J; Cesson V; Kalejta K; Olive D; Michielin O; Speiser DE; Zoete V; Derré L; Rodziewicz-Motowidło S
PLoS One; 2017; 12(6):e0179201. PubMed ID: 28594868
[TBL] [Abstract][Full Text] [Related]
20. BTLA and HVEM cross talk regulates inhibition and costimulation.
Gavrieli M; Sedy J; Nelson CA; Murphy KM
Adv Immunol; 2006; 92():157-85. PubMed ID: 17145304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]